Matthew D. Wilcox

1.8k total citations
37 papers, 1.4k citations indexed

About

Matthew D. Wilcox is a scholar working on Molecular Biology, Pharmaceutical Science and Nutrition and Dietetics. According to data from OpenAlex, Matthew D. Wilcox has authored 37 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Pharmaceutical Science and 9 papers in Nutrition and Dietetics. Recurrent topics in Matthew D. Wilcox's work include Advanced Drug Delivery Systems (9 papers), Diet and metabolism studies (8 papers) and Carbohydrate Chemistry and Synthesis (5 papers). Matthew D. Wilcox is often cited by papers focused on Advanced Drug Delivery Systems (9 papers), Diet and metabolism studies (8 papers) and Carbohydrate Chemistry and Synthesis (5 papers). Matthew D. Wilcox collaborates with scholars based in United Kingdom, Austria and Ireland. Matthew D. Wilcox's co-authors include Jeffrey P. Pearson, Peter I. Chater, Andreas Bernkop‐Schnürch, Iain A. Brownlee, Irene Pereira de Sousa, David Houghton, Sarah Dünnhaupt, Peter C. Griffiths, Beatrice Cattoz and Peter W. Dettmar and has published in prestigious journals such as SHILAP Revista de lepidopterología, Advanced Drug Delivery Reviews and Scientific Reports.

In The Last Decade

Matthew D. Wilcox

36 papers receiving 1.4k citations

Peers

Countries citing papers authored by Matthew D. Wilcox

Since Specialization

Citations

This map shows the geographic impact of Matthew D. Wilcox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew D. Wilcox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew D. Wilcox more than expected).

Fields of papers citing papers by Matthew D. Wilcox

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew D. Wilcox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew D. Wilcox. The network helps show where Matthew D. Wilcox may publish in the future.

Co-authorship network of co-authors of Matthew D. Wilcox

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew D. Wilcox. A scholar is included among the top collaborators of Matthew D. Wilcox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew D. Wilcox. Matthew D. Wilcox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Beyond the Benefits: A Case Study on the Complications of Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors (Euglycemic Diabetic Ketoacidosis (DKA) and Takotsubo Cardiomyopathy) 2024 ·Cureus ·(unknown), (unknown), (unknown), (unknown), Matthew D. Wilcox	0
2	The MUC2 Gene Product: Polymerisation and Post-Secretory Organisation—Current Models 2024 ·Polymers ·(unknown), (unknown), Peter I. Chater, Matthew D. Wilcox, (unknown), (unknown), Jeffrey P. Pearson	10
3	Pulmonary Artery Denervation as a New Therapeutic Option for Pulmonary Hypertension: A Systematic Review and Meta-Analysis 2023 ·Current Problems in Cardiology ·(unknown), (unknown), (unknown), (unknown), (unknown), Matthew D. Wilcox	4
4	A clinical review of the potential role of microaspiration and a dysregulated aerodigestive microbiome in lung disease 2023 ·Newcastle University ePrints (Newcastle Univesity) ·(unknown), (unknown), Melissa J. McDonnell, (unknown), (unknown), Matthew D. Wilcox, Peter I. Chater, Jeffrey P. Pearson, Chris Ward	1
5	The efficacy of biosynthesized silver nanoparticles against Pseudomonas aeruginosa isolates from cystic fibrosis patients 2023 ·Scientific Reports ·(unknown), (unknown), (unknown), Saja Hamed, Borhan Albiss, (unknown), (unknown), (unknown), (unknown), Ashraf I. Khasawneh, (unknown), (unknown), (unknown), Matthew D. Wilcox, Jeffrey P. Pearson, Chris Ward	27
6	White kidney bean extract as a nutraceutical: effects on gut microbiota, alpha-amylase inhibition, and user experiences 2023 ·SHILAP Revista de lepidopterología ·David Houghton, Oliver M. Shannon, Peter I. Chater, Matthew D. Wilcox, Jeffrey P. Pearson, (unknown), (unknown), Leah Avery, Alasdair Blain, (unknown), (unknown), (unknown), Andrew Nelson, Christopher J. Stewart, Fiona C. Malcomson	5
7	Exposure to bile and gastric juice can impact the aerodigestive microbiome in people with cystic fibrosis 2022 ·Scientific Reports ·(unknown), Audrey Perry, Andrew Nelson, Christopher J. Stewart, (unknown), (unknown), Andrew Robertson, Stephen Bourke, Simon Doe, Stephen Cummings, Alan Anderson, (unknown), Ian Forrest, S M Griffin, Matthew D. Wilcox, Malcolm Brodlie, Jeffrey P. Pearson, Chris Ward	6
8	A Pilot Pre and Post 4 Week Intervention Evaluating the Effect of a Proprietary, Powdered, Plant Based Food on Micronutrient Status, Dietary Intake, and Markers of Health in a Healthy Adult Population 2022 ·Frontiers in Nutrition ·Matthew D. Wilcox, Peter I. Chater, (unknown), Rebecca Williams, Iain A. Brownlee, Jeffrey P. Pearson	1
9	In vitro modelling of the mucosa of the oesophagus and upper digestive tract: narrative review 2022 ·Newcastle University ePrints (Newcastle Univesity) ·(unknown), Peter I. Chater, Iain A. Brownlee, Matthew D. Wilcox, Chris Ward, Jeffrey P. Pearson	2
10	The effect of seaweed enriched bread on carbohydrate digestion and the release of glucose from food 2021 ·Journal of Functional Foods ·Matthew D. Wilcox, Paul Cherry, Peter I. Chater, Xing Yang, (unknown), Edward J. Okello, Chris J. Seal, Jeffrey P. Pearson	9
11	Evolutionary conservation of the antimicrobial function of mucus: a first defence against infection 2018 ·npj Biofilms and Microbiomes ·(unknown), (unknown), Mike Althaus, Matthew D. Wilcox, Jeffrey P. Pearson, John C. Bythell, J. Grant Burgess	111
12	Evaluation of the cytotoxicity, genotoxicity and mucus permeation capacity of several surface modified poly(anhydride) nanoparticles designed for oral drug delivery 2016 ·International Journal of Pharmaceutics ·Tamara Iglesias, Adela López de Ceráin, Juan M. Irache, Nekane Martín‐Arbella, Matthew D. Wilcox, Jeffrey P. Pearson, Amaya Azqueta	29
13	Methods to determine the interactions of micro- and nanoparticles with mucus 2015 ·European Journal of Pharmaceutics and Biopharmaceutics ·(unknown), Sarah Dünnhaupt, Beatrice Cattoz, Peter C. Griffiths, Sejin Oh, Salvador Borrós, Matthew D. Wilcox, Jeffrey P. Pearson, Mark Gumbleton, Muthanna Abdulkarim, Irene Pereira de Sousa, Andreas Bernkop‐Schnürch	101
14	Optimal design for studying mucoadhesive polymers interaction with gastric mucin using a quartz crystal microbalance with dissipation (QCM-D): Comparison of two different mucin origins 2015 ·European Journal of Pharmaceutics and Biopharmaceutics ·Sejin Oh, Matthew D. Wilcox, Jeffrey P. Pearson, Salvador Borrós	50
15	Mucus permeating carriers: formulation and characterization of highly densely charged nanoparticles 2015 ·European Journal of Pharmaceutics and Biopharmaceutics ·Irene Pereira de Sousa, (unknown), Matthias Schmutzler, Matthew D. Wilcox, G.J. Veldhuis, Jeffrey P. Pearson, Christian W. Huck, Willi Salvenmoser, Andreas Bernkop‐Schnürch	118
16	Nanoparticles decorated with proteolytic enzymes, a promising strategy to overcome the mucus barrier 2015 ·European Journal of Pharmaceutics and Biopharmaceutics ·Irene Pereira de Sousa, Beatrice Cattoz, Matthew D. Wilcox, Peter C. Griffiths, Robert M. Dalgliesh, Sarah E. Rogers, Andreas Bernkop‐Schnürch	121
17	The effect of nanoparticle permeation on the bulk rheological properties of mucus from the small intestine 2015 ·European Journal of Pharmaceutics and Biopharmaceutics ·Matthew D. Wilcox, (unknown), Peter I. Chater, Irene Pereira de Sousa, Jeffrey P. Pearson	40
18	Biological activity of alginate and its effect on pancreatic lipase inhibition as a potential treatment for obesity 2015 ·Food Hydrocolloids ·David Houghton, Matthew D. Wilcox, Peter I. Chater, Iain A. Brownlee, Chris J. Seal, Jeffrey P. Pearson	64
19	The modulation of pancreatic lipase activity by alginates 2013 ·Food Chemistry ·Matthew D. Wilcox, Iain A. Brownlee, J. C. Richardson, Peter W. Dettmar, Jeffrey P. Pearson	89
20	Physiological parameters governing the action of pancreatic lipase 2010 ·Nutrition Research Reviews ·Iain A. Brownlee, (unknown), Matthew D. Wilcox, Peter W. Dettmar, Chris J. Seal, Jeff Pearson	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact